TMDX

TransMedics Group Inc (TMDX)

US
$ 111.519.64%

Price Chart

Key Statistics

Market Cap
$ 3.77B
P/E Ratio
78.52
Revenue (TTM)
$ 488.23M
Volume
4.42M
52W High
$ 120.93
52W Low
$ 89.65
Dividend Yield
0.00%
Beta
1.90

Technicals

50-Day MA
78.19
200-Day MA
99.893
52 Week High
120.9299
52 Week Low
89.65

About TMDX

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.

Employees
728
Headquarters
Andover, MA
CEO
Dr. Waleed H. Hassanein M.D.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Losers

Symbol/Name
LTP
% Chg